Rxivist logo

Author: Warren Kalina

  • Most recently observed institution: Vaccine Research and Development, Pfizer, Inc.

Rankings

  • All-time downloads: 165,474 (rank: 506 )
  • Categories:
    • infectious diseases: 165,474 (rank: 107 (tie) )

Downloads per author, site-wide

Preprints

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 72,083 times
  • Download rankings, all-time:
    • Site-wide: 79
    • In infectious diseases: 30
  • Year to date:
    • Site-wide: 73
  • Since beginning of last month:
    • Site-wide: 79

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 69,907 times
  • Download rankings, all-time:
    • Site-wide: 82
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 258
  • Since beginning of last month:
    • Site-wide: 351

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 23,484 times
  • Download rankings, all-time:
    • Site-wide: 320
    • In infectious diseases: 118
  • Year to date:
    • Site-wide: 623
  • Since beginning of last month:
    • Site-wide: 1,298

PanLingua

News